The opioid epidemic has led medical professionals and patients to explore alternatives to potentially addictive pharmaceuticals, such as light therapy.
Photobiomodulation (PBM) therapy, a form of light therapy using red and near-infrared light to stimulate cell growth and reduce inflammation, is gradually gaining acceptance by the medical community. The noninvasive technology, discovered in 1967, is approved by the U.S. Food and Drug Administration (FDA) to manage pain and treat a variety of medical conditions.
Patients receive therapy several times a week for several weeks before they see pain relief.
Read more from the Author Kevin Stone on Heartland Daily News.